+91 9815326901

  • Why Us

    Strength


    Organic Labs has a workforce of over 4000 multifunctional and multicultural employees, motivated towards higher standards of customer satisfaction.

    2200+ Stockists accross India serving over 50 Lakh customers.

    A strong prescribing doctor’s base of over 2.50Lacs.

    Ind-Swift possesses a portfolio of over 750 products.

    It has a marked presence in high growth therapeutic segments of Cardiology, Diabetology, Anti-depressant, Anti-allergic, Anti-Infective, Neurology and Oncology.

    It is the world's largest manufacturer of Clarithromycin, Azithromycin and Fexofenadine.

    Ranking

    Organic Labs is ranked 90th among the top Indian Pharmaceutical companies in India.

    It is among the fortune 500 companies of India.

    It is ranked the 101st largest pharma company in the global market by Plimsoll Global Analysis.

    Production

    Organic Labs possesses state-of-the-art manufacturing facilities for finished Dosage Forms & API's conforming to the most stringent international norms of WHO-GMP.

    Organic Labs has a manufacturing capacity of (Finished Dosage) :

    2300 million Tablets

    64 million Ampoules

    27 million Vials

    84 million Capsules

    18 million Dermatological products

    62 million Oral liquid bottles

    Major Break Throughs

    Organic Labs has filed more than 680 dossiers for registration in more than 20 Countries around the world stretching from South America to Philippines.

    It has developed Netazoxanide Anti-Diarrheal drug for the first time in India after successful clinical trials and bio-equivalence studies.

    It has strong capacity to develop non infringing API's requiring Complex Chemistry and Multiple reactions.

    Organic Labs has developed taste masking technology of macrolides for the first time in India.

    Organic Labs has developed the sustained release process of Isoxsuprine HCL tablets for the first time in India.

    Organic Labs has developed the mouth desolving tablet.

    Cart (0)